Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: February 27, 2026, 8:00 pm
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 500830 | NSE: COLPAL

Colgate-Palmolive (India) Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: February 27, 2026, 8:00 pm

Market Cap 61,318 Cr.
Current Price 2,254
Intrinsic Value₹1,885.24
High / Low 2,747/2,029
Stock P/E46.0
Book Value 58.2
Dividend Yield2.26 %
ROCE105 %
ROE81.2 %
Face Value 1.00
PEG Ratio10.86

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Colgate-Palmolive (India) Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Honasa Consumer Ltd 9,864 Cr. 303 334/19063.8 38.80.00 %7.44 %5.51 % 10.0
Ambica Agarbathies Aroma & Industries Ltd 43.8 Cr. 25.4 33.0/22.363.4 65.20.00 %7.49 %0.45 % 10.0
Ador Multi Products Ltd 109 Cr. 114 149/23.5 32.50.00 %11.4 %3.09 % 10.0
Kaya Ltd 493 Cr. 324 488/204 60.90.00 %2.50 %% 10.0
Jyothy Labs Ltd 9,318 Cr. 253 400/23725.5 55.81.38 %24.6 %19.0 % 1.00
Industry Average70,048.50 Cr1,831.7451.64112.700.86%29.21%23.91%4.94

All Competitor Stocks of Colgate-Palmolive (India) Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 1,2911,3511,3241,4711,3961,4901,4971,6191,4621,4631,4341,5201,486
Expenses 9308999069899279589881,1221,0079649811,0541,044
Operating Profit 361452418482468532508497454498453465442
OPM % 28%33%32%33%34%36%34%31%31%34%32%31%30%
Other Income 1018-521182323762019181531
Interest 1111211111111
Depreciation 44434444414242424138383736
Profit before tax 327426369458443511489530433478432442436
Tax % 26%26%26%26%26%26%26%26%25%26%26%26%26%
Net Profit 243316274340330380364395323355321328324
EPS in Rs 8.9411.6310.0612.5012.1413.9613.3814.5211.8713.0511.7912.0411.91

Last Updated: February 7, 2026, 12:02 am

Below is a detailed analysis of the quarterly data for Colgate-Palmolive (India) Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:

  • For Sales, as of Dec 2025, the value is 1,486.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,520.00 Cr. (Sep 2025) to 1,486.00 Cr., marking a decrease of 34.00 Cr..
  • For Expenses, as of Dec 2025, the value is 1,044.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,054.00 Cr. (Sep 2025) to 1,044.00 Cr., marking a decrease of 10.00 Cr..
  • For Operating Profit, as of Dec 2025, the value is 442.00 Cr.. The value appears to be declining and may need further review. It has decreased from 465.00 Cr. (Sep 2025) to 442.00 Cr., marking a decrease of 23.00 Cr..
  • For OPM %, as of Dec 2025, the value is 30.00%. The value appears to be declining and may need further review. It has decreased from 31.00% (Sep 2025) to 30.00%, marking a decrease of 1.00%.
  • For Other Income, as of Dec 2025, the value is 31.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Sep 2025) to 31.00 Cr., marking an increase of 16.00 Cr..
  • For Interest, as of Dec 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 1.00 Cr..
  • For Depreciation, as of Dec 2025, the value is 36.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 37.00 Cr. (Sep 2025) to 36.00 Cr., marking a decrease of 1.00 Cr..
  • For Profit before tax, as of Dec 2025, the value is 436.00 Cr.. The value appears to be declining and may need further review. It has decreased from 442.00 Cr. (Sep 2025) to 436.00 Cr., marking a decrease of 6.00 Cr..
  • For Tax %, as of Dec 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 26.00%.
  • For Net Profit, as of Dec 2025, the value is 324.00 Cr.. The value appears to be declining and may need further review. It has decreased from 328.00 Cr. (Sep 2025) to 324.00 Cr., marking a decrease of 4.00 Cr..
  • For EPS in Rs, as of Dec 2025, the value is 11.91. The value appears to be declining and may need further review. It has decreased from 12.04 (Sep 2025) to 11.91, marking a decrease of 0.13.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 18, 2026, 1:15 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 3,5793,9823,8683,9824,1884,4624,5254,8415,1005,2265,6806,0405,902
Expenses 2,9153,1592,9293,0383,0743,2263,3233,3313,5343,6793,7794,0824,044
Operating Profit 6648239409441,1141,2361,2021,5101,5661,5471,9011,9581,858
OPM % 19%21%24%24%27%28%27%31%31%30%33%32%31%
Other Income 115327412668493026425713983
Interest 00000210765544
Depreciation 5175111133157159198182177175172163149
Profit before tax 7287808358519831,1431,0431,3501,4091,4101,7811,9301,788
Tax % 26%28%30%32%32%32%22%23%23%26%26%26%
Net Profit 5405595815776737768161,0351,0781,0471,3241,4371,327
EPS in Rs 19.8520.5521.3721.2324.7628.5230.0238.0739.6538.5048.6752.8348.79
Dividend Payout % 68%58%47%47%97%81%93%100%101%101%119%97%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)3.52%3.94%-0.69%16.64%15.30%5.15%26.84%4.15%-2.88%26.46%8.53%
Change in YoY Net Profit Growth (%)0.00%0.42%-4.62%17.33%-1.33%-10.15%21.68%-22.68%-7.03%29.33%-17.92%

Colgate-Palmolive (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:4%
5 Years:6%
3 Years:6%
TTM:2%
Compounded Profit Growth
10 Years:10%
5 Years:12%
3 Years:10%
TTM:-1%
Stock Price CAGR
10 Years:10%
5 Years:13%
3 Years:14%
1 Year:-33%
Return on Equity
10 Years:64%
5 Years:73%
3 Years:72%
Last Year:81%

Last Updated: September 4, 2025, 9:30 pm

Balance Sheet

Last Updated: December 4, 2025, 12:51 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 14142727272727272727272727
Reserves 5867571,0041,2471,4971,4201,5671,1391,7071,6891,8471,6371,555
Borrowings 0000083102918369726160
Other Liabilities 8949329721,0371,0391,0979081,6371,0841,0981,2501,2931,535
Total Liabilities 1,4931,7022,0032,3112,5642,6262,6042,8942,9022,8833,1973,0193,178
Fixed Assets 5567821,0081,1081,1461,1911,1231,065963862794776742
CWIP 142141781671591991901451221141103829
Investments 373731313131191900000
Other Assets 7597428851,0051,2281,2061,2721,6661,8171,9072,2922,2042,406
Total Assets 1,4931,7022,0032,3112,5642,6262,6042,8942,9022,8833,1973,0193,178

Below is a detailed analysis of the balance sheet data for Colgate-Palmolive (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 27.00 Cr..
  • For Reserves, as of Sep 2025, the value is 1,555.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,637.00 Cr. (Mar 2025) to 1,555.00 Cr., marking a decrease of 82.00 Cr..
  • For Borrowings, as of Sep 2025, the value is 60.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 61.00 Cr. (Mar 2025) to 60.00 Cr., marking a decrease of 1.00 Cr..
  • For Other Liabilities, as of Sep 2025, the value is 1,535.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,293.00 Cr. (Mar 2025) to 1,535.00 Cr., marking an increase of 242.00 Cr..
  • For Total Liabilities, as of Sep 2025, the value is 3,178.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,019.00 Cr. (Mar 2025) to 3,178.00 Cr., marking an increase of 159.00 Cr..
  • For Fixed Assets, as of Sep 2025, the value is 742.00 Cr.. The value appears to be declining and may need further review. It has decreased from 776.00 Cr. (Mar 2025) to 742.00 Cr., marking a decrease of 34.00 Cr..
  • For CWIP, as of Sep 2025, the value is 29.00 Cr.. The value appears to be declining and may need further review. It has decreased from 38.00 Cr. (Mar 2025) to 29.00 Cr., marking a decrease of 9.00 Cr..
  • For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
  • For Other Assets, as of Sep 2025, the value is 2,406.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,204.00 Cr. (Mar 2025) to 2,406.00 Cr., marking an increase of 202.00 Cr..
  • For Total Assets, as of Sep 2025, the value is 3,178.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,019.00 Cr. (Mar 2025) to 3,178.00 Cr., marking an increase of 159.00 Cr..

Notably, the Reserves (1,555.00 Cr.) exceed the Borrowings (60.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 4576386896886949839307841,6261,1761,1991,394
Cash from Investing Activity + -180-272-237-342-207-96-1971-108-87956
Cash from Financing Activity + -422-385-391-341-380-815-891-956-1,091-1,087-1,195-1,671
Net Cash Flow -145-186151077320-1014278283-221

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow664.00823.00940.00944.001.00-82.00-101.00-90.00-82.00-68.00-71.00-60.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 661012181711916111114
Inventory Days 596372725658697978686376
Days Payable 130128136148152144142179169155187185
Cash Conversion Cycle -65-59-55-63-79-68-63-91-75-76-113-95
Working Capital Days -47-40-43-39-33-36-23-84-25-32-46-37
ROCE %122%114%96%74%71%73%65%92%92%79%97%105%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 51.00%51.00%51.00%51.00%51.00%51.00%51.00%51.00%51.00%51.00%51.00%51.00%
FIIs 21.50%21.80%24.08%24.62%24.51%24.44%24.94%23.72%22.23%20.39%17.16%15.18%
DIIs 7.34%7.52%5.59%5.60%5.82%5.72%5.55%6.57%7.84%9.34%11.95%13.50%
Government 0.28%0.28%0.28%0.28%0.28%0.28%0.28%0.28%0.28%0.28%0.28%0.28%
Public 19.87%19.41%19.03%18.50%18.38%18.54%18.22%18.44%18.65%19.00%19.59%20.03%
No. of Shareholders 2,66,8272,52,9552,37,9072,38,2002,31,0612,48,8012,39,1932,65,3372,82,9733,05,2223,32,4093,37,608

Shareholding Pattern Chart

No. of Shareholders

Colgate-Palmolive (India) Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
SBI Large & Midcap Fund 4,160,742 2.35 879.661,903,6622026-02-23 05:01:45118.57%
Nippon India Multi Cap Fund 1,692,665 0.73 357.86500,4732025-12-08 02:19:27238.21%
SBI Midcap Fund 1,500,000 1.41 317.13N/AN/AN/A
Nippon India Growth Mid Cap Fund 1,300,000 0.66 274.851,100,0002026-01-26 04:10:2618.18%
SBI MNC Fund 1,000,000 3.77 211.42800,0002026-02-23 05:01:4525%
HDFC Mid Cap Fund 801,989 0.18 169.56N/AN/AN/A
Nippon India Large Cap Fund 741,204 0.31 156.71600,6772026-02-23 05:01:4523.39%
SBI Dividend Yield Fund 720,000 1.71 152.22N/AN/AN/A
Sundaram Mid Cap Fund 675,628 1.11 142.84670,2772026-02-23 05:01:450.8%
SBI Consumption Opportunities Fund 475,000 3.43 100.42425,0002026-01-26 00:48:4111.76%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.001.001.001.00
Basic EPS (Rs.) 52.8348.6738.5039.6538.07
Diluted EPS (Rs.) 52.8348.6738.5039.6538.07
Cash EPS (Rs.) 58.8154.9744.9346.1644.78
Book Value[Excl.RevalReserv]/Share (Rs.) 61.1968.9163.1163.7842.86
Book Value[Incl.RevalReserv]/Share (Rs.) 61.1968.9163.1163.7842.86
Dividend / Share (Rs.) 51.0058.0039.0040.0038.00
Revenue From Operations / Share (Rs.) 222.07208.85192.15187.50178.00
PBDIT / Share (Rs.) 77.0972.7058.8558.5456.62
PBIT / Share (Rs.) 71.1166.3952.4252.0249.91
PBT / Share (Rs.) 70.9565.4951.8351.8049.64
Net Profit / Share (Rs.) 52.8248.6738.5039.6538.07
PBDIT Margin (%) 34.7134.8030.6231.2231.80
PBIT Margin (%) 32.0231.7927.2827.7428.04
PBT Margin (%) 31.9531.3526.9727.6227.89
Net Profit Margin (%) 23.7823.3020.0321.1421.38
Return on Networth / Equity (%) 86.3270.6161.0062.1688.80
Return on Capital Employeed (%) 111.0692.2679.2877.76106.38
Return On Assets (%) 47.5941.4036.3237.1535.77
Asset Turnover Ratio (%) 1.941.871.811.761.76
Current Ratio (X) 1.381.541.431.370.84
Quick Ratio (X) 1.081.301.121.040.64
Inventory Turnover Ratio (X) 17.934.614.313.953.95
Dividend Payout Ratio (NP) (%) 113.5788.35101.2947.92141.85
Dividend Payout Ratio (CP) (%) 102.0278.2286.8041.15120.59
Earning Retention Ratio (%) -13.5711.65-1.2952.08-41.85
Cash Earning Retention Ratio (%) -2.0221.7813.2058.85-20.59
Interest Coverage Ratio (X) 485.39395.76325.74270.10212.15
Interest Coverage Ratio (Post Tax) (X) 333.59269.83216.38183.92143.63
Enterprise Value (Cr.) 63942.7972358.9040063.9441171.9341551.30
EV / Net Operating Revenue (X) 10.5912.747.678.078.58
EV / EBITDA (X) 30.4936.5925.0325.8626.98
MarketCap / Net Operating Revenue (X) 10.7712.987.848.228.76
Retention Ratios (%) -13.5711.64-1.2952.07-41.85
Price / BV (X) 39.0739.3423.8824.1736.38
Price / Net Operating Revenue (X) 10.7712.987.848.228.76
EarningsYield 0.020.010.020.020.02

After reviewing the key financial ratios for Colgate-Palmolive (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
  • For Basic EPS (Rs.), as of Mar 25, the value is 52.83. This value is within the healthy range. It has increased from 48.67 (Mar 24) to 52.83, marking an increase of 4.16.
  • For Diluted EPS (Rs.), as of Mar 25, the value is 52.83. This value is within the healthy range. It has increased from 48.67 (Mar 24) to 52.83, marking an increase of 4.16.
  • For Cash EPS (Rs.), as of Mar 25, the value is 58.81. This value is within the healthy range. It has increased from 54.97 (Mar 24) to 58.81, marking an increase of 3.84.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 61.19. It has decreased from 68.91 (Mar 24) to 61.19, marking a decrease of 7.72.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 61.19. It has decreased from 68.91 (Mar 24) to 61.19, marking a decrease of 7.72.
  • For Dividend / Share (Rs.), as of Mar 25, the value is 51.00. This value exceeds the healthy maximum of 3. It has decreased from 58.00 (Mar 24) to 51.00, marking a decrease of 7.00.
  • For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 222.07. It has increased from 208.85 (Mar 24) to 222.07, marking an increase of 13.22.
  • For PBDIT / Share (Rs.), as of Mar 25, the value is 77.09. This value is within the healthy range. It has increased from 72.70 (Mar 24) to 77.09, marking an increase of 4.39.
  • For PBIT / Share (Rs.), as of Mar 25, the value is 71.11. This value is within the healthy range. It has increased from 66.39 (Mar 24) to 71.11, marking an increase of 4.72.
  • For PBT / Share (Rs.), as of Mar 25, the value is 70.95. This value is within the healthy range. It has increased from 65.49 (Mar 24) to 70.95, marking an increase of 5.46.
  • For Net Profit / Share (Rs.), as of Mar 25, the value is 52.82. This value is within the healthy range. It has increased from 48.67 (Mar 24) to 52.82, marking an increase of 4.15.
  • For PBDIT Margin (%), as of Mar 25, the value is 34.71. This value is within the healthy range. It has decreased from 34.80 (Mar 24) to 34.71, marking a decrease of 0.09.
  • For PBIT Margin (%), as of Mar 25, the value is 32.02. This value exceeds the healthy maximum of 20. It has increased from 31.79 (Mar 24) to 32.02, marking an increase of 0.23.
  • For PBT Margin (%), as of Mar 25, the value is 31.95. This value is within the healthy range. It has increased from 31.35 (Mar 24) to 31.95, marking an increase of 0.60.
  • For Net Profit Margin (%), as of Mar 25, the value is 23.78. This value exceeds the healthy maximum of 10. It has increased from 23.30 (Mar 24) to 23.78, marking an increase of 0.48.
  • For Return on Networth / Equity (%), as of Mar 25, the value is 86.32. This value is within the healthy range. It has increased from 70.61 (Mar 24) to 86.32, marking an increase of 15.71.
  • For Return on Capital Employeed (%), as of Mar 25, the value is 111.06. This value is within the healthy range. It has increased from 92.26 (Mar 24) to 111.06, marking an increase of 18.80.
  • For Return On Assets (%), as of Mar 25, the value is 47.59. This value is within the healthy range. It has increased from 41.40 (Mar 24) to 47.59, marking an increase of 6.19.
  • For Asset Turnover Ratio (%), as of Mar 25, the value is 1.94. It has increased from 1.87 (Mar 24) to 1.94, marking an increase of 0.07.
  • For Current Ratio (X), as of Mar 25, the value is 1.38. This value is below the healthy minimum of 1.5. It has decreased from 1.54 (Mar 24) to 1.38, marking a decrease of 0.16.
  • For Quick Ratio (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has decreased from 1.30 (Mar 24) to 1.08, marking a decrease of 0.22.
  • For Inventory Turnover Ratio (X), as of Mar 25, the value is 17.93. This value exceeds the healthy maximum of 8. It has increased from 4.61 (Mar 24) to 17.93, marking an increase of 13.32.
  • For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 113.57. This value exceeds the healthy maximum of 50. It has increased from 88.35 (Mar 24) to 113.57, marking an increase of 25.22.
  • For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 102.02. This value exceeds the healthy maximum of 50. It has increased from 78.22 (Mar 24) to 102.02, marking an increase of 23.80.
  • For Earning Retention Ratio (%), as of Mar 25, the value is -13.57. This value is below the healthy minimum of 40. It has decreased from 11.65 (Mar 24) to -13.57, marking a decrease of 25.22.
  • For Cash Earning Retention Ratio (%), as of Mar 25, the value is -2.02. This value is below the healthy minimum of 40. It has decreased from 21.78 (Mar 24) to -2.02, marking a decrease of 23.80.
  • For Interest Coverage Ratio (X), as of Mar 25, the value is 485.39. This value is within the healthy range. It has increased from 395.76 (Mar 24) to 485.39, marking an increase of 89.63.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 333.59. This value is within the healthy range. It has increased from 269.83 (Mar 24) to 333.59, marking an increase of 63.76.
  • For Enterprise Value (Cr.), as of Mar 25, the value is 63,942.79. It has decreased from 72,358.90 (Mar 24) to 63,942.79, marking a decrease of 8,416.11.
  • For EV / Net Operating Revenue (X), as of Mar 25, the value is 10.59. This value exceeds the healthy maximum of 3. It has decreased from 12.74 (Mar 24) to 10.59, marking a decrease of 2.15.
  • For EV / EBITDA (X), as of Mar 25, the value is 30.49. This value exceeds the healthy maximum of 15. It has decreased from 36.59 (Mar 24) to 30.49, marking a decrease of 6.10.
  • For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 10.77. This value exceeds the healthy maximum of 3. It has decreased from 12.98 (Mar 24) to 10.77, marking a decrease of 2.21.
  • For Retention Ratios (%), as of Mar 25, the value is -13.57. This value is below the healthy minimum of 30. It has decreased from 11.64 (Mar 24) to -13.57, marking a decrease of 25.21.
  • For Price / BV (X), as of Mar 25, the value is 39.07. This value exceeds the healthy maximum of 3. It has decreased from 39.34 (Mar 24) to 39.07, marking a decrease of 0.27.
  • For Price / Net Operating Revenue (X), as of Mar 25, the value is 10.77. This value exceeds the healthy maximum of 3. It has decreased from 12.98 (Mar 24) to 10.77, marking a decrease of 2.21.
  • For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Colgate-Palmolive (India) Ltd as of February 27, 2026 is: ₹1,778.41

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of February 27, 2026, Colgate-Palmolive (India) Ltd is Overvalued by 21.10% compared to the current share price ₹2,254.00

Intrinsic Value of Colgate-Palmolive (India) Ltd as of February 27, 2026 is: ₹1,853.74

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of February 27, 2026, Colgate-Palmolive (India) Ltd is Overvalued by 17.76% compared to the current share price ₹2,254.00

Last 5 Year EPS CAGR: 4.24%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 90.00%, which is a positive sign.
  2. The stock has a low average Working Capital Days of -40.42, which is a positive sign.
  3. The stock has a low average Cash Conversion Cycle of -75.17, which is a positive sign.
  4. The company has higher reserves (1,357.85 cr) compared to borrowings (47.77 cr), indicating strong financial stability.
  5. The company has shown consistent growth in sales (4.15 cr) and profit (321.92 cr) over the years.

    Stock Analysis

    • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Colgate-Palmolive (India) Ltd:
      1. Net Profit Margin: 23.78%
        • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
      2. ROCE: 111.06% (Industry Average ROCE: 29.21%)
        • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
      3. ROE%: 86.32% (Industry Average ROE: 23.91%)
        • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
      4. Interest Coverage Ratio (Post Tax): 333.59
        • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
      5. Quick Ratio: 1.08
        • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
      6. Stock P/E: 46 (Industry average Stock P/E: 51.64)
        • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
      7. Total Debt / Equity: 0
        • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
      The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
      Stock Rating:

    About the Company - Qualitative Analysis

    Colgate-Palmolive (India) Ltd. is a Public Limited Listed company incorporated on 23/09/1937 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24200MH1937PLC002700 and registration number is 002700. Currently Company is involved in the business activities of Manufacture of other chemical products. Company's Total Operating Revenue is Rs. 6040.17 Cr. and Equity Capital is Rs. 27.20 Cr. for the Year ended 31/03/2025.
    INDUSTRYADDRESSCONTACT
    Personal CareColgate Research Centre, Main Street, Mumbai Maharashtra 400076Contact not found
    Management
    NamePosition Held
    Mr. Mukul DeorasChairman
    Ms. Prabha NarasimhanManaging Director & CEO
    Mr. M S JacobWholeTime Director & CFO
    Mr. Surender SharmaWhole Time Director
    Mr. Sekhar NatarajanInd. Non-Executive Director
    Ms. Sukanya KripaluInd. Non-Executive Director
    Ms. Gopika PantInd. Non-Executive Director
    Dr. Indu BhushanInd. Non-Executive Director
    Mr. Sanjay GuptaInd. Non-Executive Director

    FAQ

    What is the intrinsic value of Colgate-Palmolive (India) Ltd?

    Colgate-Palmolive (India) Ltd's intrinsic value (as of 27 February 2026) is ₹1853.74 which is 17.76% lower the current market price of ₹2,254.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹61,318 Cr. market cap, FY2025-2026 high/low of ₹2,747/2,029, reserves of ₹1,555 Cr, and liabilities of ₹3,178 Cr.

    What is the Market Cap of Colgate-Palmolive (India) Ltd?

    The Market Cap of Colgate-Palmolive (India) Ltd is 61,318 Cr..

    What is the current Stock Price of Colgate-Palmolive (India) Ltd as on 27 February 2026?

    The current stock price of Colgate-Palmolive (India) Ltd as on 27 February 2026 is ₹2,254.

    What is the High / Low of Colgate-Palmolive (India) Ltd stocks in FY 2025-2026?

    In FY 2025-2026, the High / Low of Colgate-Palmolive (India) Ltd stocks is ₹2,747/2,029.

    What is the Stock P/E of Colgate-Palmolive (India) Ltd?

    The Stock P/E of Colgate-Palmolive (India) Ltd is 46.0.

    What is the Book Value of Colgate-Palmolive (India) Ltd?

    The Book Value of Colgate-Palmolive (India) Ltd is 58.2.

    What is the Dividend Yield of Colgate-Palmolive (India) Ltd?

    The Dividend Yield of Colgate-Palmolive (India) Ltd is 2.26 %.

    What is the ROCE of Colgate-Palmolive (India) Ltd?

    The ROCE of Colgate-Palmolive (India) Ltd is 105 %.

    What is the ROE of Colgate-Palmolive (India) Ltd?

    The ROE of Colgate-Palmolive (India) Ltd is 81.2 %.

    What is the Face Value of Colgate-Palmolive (India) Ltd?

    The Face Value of Colgate-Palmolive (India) Ltd is 1.00.

    Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Colgate-Palmolive (India) Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
    Explore Industry-wise Stock Analysis Reports